US Stock MarketDetailed Quotes

CGON CG Oncology

Watchlist

30.810
+1.840+6.35%

Close May 22 16:00 ET

2.05BMarket Cap-28396P/E (TTM)

CG Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(FY)Dec 31, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-225.72%-26.01M

-53.26%-45.68M

-135.19%-16.06M

-7.99M

-118.28%-29.8M

-6.83M

-13.65M

Net income from continuing operations

-95.36%-16.93M

-37.14%-48.61M

-92.04%-16.12M

---8.67M

-176.06%-35.44M

---8.39M

---12.84M

Operating gains losses

----

---372K

Depreciation and amortization

0.00%4K

13.33%17K

0.00%4K

--4K

50.00%15K

--4K

--10K

Other non cash items

-102.40%-3K

60.90%819K

-113.08%-14K

--125K

26.62%509K

--107K

--402K

Change In working capital

-2,351.74%-8.4M

-22.53%3.44M

65.80%2.16M

--373K

325.67%4.44M

--1.3M

---1.97M

-Change in prepaid assets

-2,624.11%-5.65M

-353.77%-2.72M

-168.92%-490K

--224K

153.76%1.07M

--711K

---2M

-Change in payables and accrued expense

-1,920.13%-2.71M

85.55%6.15M

347.22%2.65M

--149K

2,807.02%3.31M

--593K

--114K

-Change in other current assets

---33K

-75.00%13K

--0

161.18%52K

--0

---85K

Cash from discontinued investing activities

Operating cash flow

-225.72%-26.01M

-53.26%-45.68M

-135.19%-16.06M

---7.99M

-118.28%-29.8M

---6.83M

---13.65M

Investing cash flow

Cash flow from continuing investing activities

-290.66%-307.44M

-118.95%-121.2M

130.62%16.94M

-78.7M

-56,963.92%-55.35M

-55.34M

-97K

Net PPE purchase and sale

---12K

--0

85.57%-14K

--1K

---97K

Net investment purchase and sale

-290.64%-307.43M

-119.01%-121.2M

130.62%16.94M

---78.7M

---55.34M

--0

Cash from discontinued investing activities

Investing cash flow

-290.66%-307.44M

-118.95%-121.2M

130.62%16.94M

---78.7M

-56,963.92%-55.35M

---55.34M

---97K

Financing cash flow

Cash flow from continuing financing activities

52,735.03%402.66M

-27.32%87M

-105.10%-2.89M

-765K

674.91%119.69M

56.7M

15.45M

Net issuance payments of debt

56.18%-365K

---16.29M

---1K

---833K

--0

--15.2M

Net common stock issuance

--406.41M

----

--0

----

Net preferred stock issuance

----

-12.47%104.63M

-100.00%2K

----

--119.53M

--56.55M

--0

Proceeds from stock option exercised by employees

--0

1,154.22%2.08M

76.35%261K

--68K

-32.24%166K

--148K

--245K

Net other financing activities

---3.39M

---3.42M

---3.15M

----

Cash from discontinued financing activities

Financing cash flow

52,735.03%402.66M

-27.32%87M

-105.10%-2.89M

---765K

674.91%119.69M

--56.7M

--15.45M

Net cash flow

Beginning cash position

-90.62%8.27M

64.42%88.14M

-89.03%10.27M

--88.14M

3.27%53.61M

--93.61M

--51.91M

Current changes in cash

179.13%69.2M

-331.29%-79.88M

63.30%-2.01M

---87.45M

1,937.52%34.54M

---5.47M

--1.7M

End cash Position

11,078.64%77.47M

-90.62%8.27M

--693K

64.42%88.14M

--88.14M

--53.61M

Free cash flow

-225.87%-26.02M

-53.19%-45.68M

-135.22%-16.06M

---7.99M

-116.84%-29.82M

---6.83M

---13.75M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-225.72%-26.01M	-53.26%-45.68M	-135.19%-16.06M	-7.99M	-118.28%-29.8M	-6.83M	-13.65M
Net income from continuing operations	-95.36%-16.93M	-37.14%-48.61M	-92.04%-16.12M	---8.67M	-176.06%-35.44M	---8.39M	---12.84M
Operating gains losses	----	----	----	----	----	----	---372K
Depreciation and amortization	0.00%4K	13.33%17K	0.00%4K	--4K	50.00%15K	--4K	--10K
Other non cash items	-102.40%-3K	60.90%819K	-113.08%-14K	--125K	26.62%509K	--107K	--402K
Change In working capital	-2,351.74%-8.4M	-22.53%3.44M	65.80%2.16M	--373K	325.67%4.44M	--1.3M	---1.97M
-Change in prepaid assets	-2,624.11%-5.65M	-353.77%-2.72M	-168.92%-490K	--224K	153.76%1.07M	--711K	---2M
-Change in payables and accrued expense	-1,920.13%-2.71M	85.55%6.15M	347.22%2.65M	--149K	2,807.02%3.31M	--593K	--114K
-Change in other current assets	---33K	-75.00%13K	--0	--0	161.18%52K	--0	---85K
Cash from discontinued investing activities
Operating cash flow	-225.72%-26.01M	-53.26%-45.68M	-135.19%-16.06M	---7.99M	-118.28%-29.8M	---6.83M	---13.65M
Investing cash flow
Cash flow from continuing investing activities	-290.66%-307.44M	-118.95%-121.2M	130.62%16.94M	-78.7M	-56,963.92%-55.35M	-55.34M	-97K
Net PPE purchase and sale	---12K	--0	--0	--0	85.57%-14K	--1K	---97K
Net investment purchase and sale	-290.64%-307.43M	-119.01%-121.2M	130.62%16.94M	---78.7M	---55.34M	---55.34M	--0
Cash from discontinued investing activities
Investing cash flow	-290.66%-307.44M	-118.95%-121.2M	130.62%16.94M	---78.7M	-56,963.92%-55.35M	---55.34M	---97K
Financing cash flow
Cash flow from continuing financing activities	52,735.03%402.66M	-27.32%87M	-105.10%-2.89M	-765K	674.91%119.69M	56.7M	15.45M
Net issuance payments of debt	56.18%-365K	---16.29M	---1K	---833K	--0	--0	--15.2M
Net common stock issuance	--406.41M	----	----	--0	----	----	----
Net preferred stock issuance	----	-12.47%104.63M	-100.00%2K	----	--119.53M	--56.55M	--0
Proceeds from stock option exercised by employees	--0	1,154.22%2.08M	76.35%261K	--68K	-32.24%166K	--148K	--245K
Net other financing activities	---3.39M	---3.42M	---3.15M	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	52,735.03%402.66M	-27.32%87M	-105.10%-2.89M	---765K	674.91%119.69M	--56.7M	--15.45M
Net cash flow
Beginning cash position	-90.62%8.27M	64.42%88.14M	-89.03%10.27M	--88.14M	3.27%53.61M	--93.61M	--51.91M
Current changes in cash	179.13%69.2M	-331.29%-79.88M	63.30%-2.01M	---87.45M	1,937.52%34.54M	---5.47M	--1.7M
End cash Position	11,078.64%77.47M	-90.62%8.27M	-90.62%8.27M	--693K	64.42%88.14M	--88.14M	--53.61M
Free cash flow	-225.87%-26.02M	-53.19%-45.68M	-135.22%-16.06M	---7.99M	-116.84%-29.82M	---6.83M	---13.75M
Currency Unit	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall